Table 3. Baseline Demographic and Clinical Characteristics of Non-RV Pacing-Dependent and Pacing-Dependent Patients at 1 Month Post-PPM Implant.
Non-RV pacing-dependent (n = 17) | RV pacing-dependent (n = 8) | P-value | |
---|---|---|---|
Age | 80.4 ± 6.3 | 80.9 ± 8.3 | 0.88 |
Gender (female) | 8/17 | 2/8 | 0.40 |
BMI | 29.1 ± 6.3 | 25.0 ± 4 .5 | 0.12 |
Hypertension | 15/17 | 5/8 | 0.28 |
DM | 10/17 | 2/8 | 0.2 |
CAD | 14/17 | 5/8 | 0.34 |
CHF | 13/17 | 5/8 | 0.64 |
COPD | 2/17 | 1/8 | 1 |
PVD | 4/17 | 1/8 | 0.64 |
History of atrial fibrillation | 6/17 | 2/8 | 0.68 |
History of atrial flutter | 1/17 | 1/8 | 1 |
eGFR < 60 | 10/17 | 7/8 | 0.21 |
Creatinine | 1.36 ± 0.61 | 1.92 ± 1.42 | 0.19 |
Prior CABG | 7/17 | 2/8 | 0.66 |
Prior PCI | 3/17 | 3/8 | 0.34 |
Prior balloon valvuloplasty | 5/17 | 0/8 | 0.14 |
ACE-I/ARB | 7/17 | 5/8 | 0.41 |
Beta-blockers | 10/17 | 6/8 | 0.66 |
Digoxin | 0/17 | 0/8 | 1 |
Other anti-arrhythmic drugs | 0/17 | 0/8 | 1 |
The P-values shown are derived from two-tailed Fisher’s exact test for categorical variables and two-tailed unpaired Student’s t-test for continuous variables. Patients who were non-RV pacing-dependent at 30 days and patients who were RV pacing-dependent at 30 days patients were separately compared with the non-pacemaker population to derive these P-values. Continuous variables are reported as the mean plus or minus the standard deviation. RV: right ventricular; PPM: permanent pacemaker; BMI: body mass index; DM: diabetes mellitus; CAD: coronary artery disease; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular disease; eGFR: estimated glomerular filtration rate; CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention; ACE-I/ARB: angiotensin converting enzyme inhibitor/angiotensin receptor blocker.